Translation of the National Institutes of Health Diabetes Prevention Program in African American Churches

Journal of the National Medical Association

Volumn 103, Issue 3, 2011, Pages 194-202

  Boltri, John M ^a   Davis Smith, Monique ^a   Okosun, Ike S ^b   Seale, J Paul ^a   Foster, Barbara ^c  

^a MERCER UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GEORGIA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Diabetes; Prevention; Research

Indexed keywords

GLUCOSE;

ADULT; AFRICAN AMERICAN; ARTICLE; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; COST; DIABETES MELLITUS; DIABETES PREVENTION PROGRAM; FEMALE; FOLLOW UP; HEALTH PROGRAM; HUMAN; MALE; PRIORITY JOURNAL; PUBLIC HEALTH; RELIGION; WEIGHT GAIN;

EID: 79956129941     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-9684(15)30301-1     Document Type: Article

References (61)

1. Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047-1053.
2. Cowie CC, Rust KF, Byrd-Holt DD, et al. Prevalence of diabetes and impaired fasting glucose in adults in the US population: National Health and Nutrition Examination Survey 1999-2002. Diabetes Care. 2006;29:1263-1268.
3. Hogan P, Dall T, Nikolov P. American Diabetes Association. Economic costs of diabetes in the US in 2002. Diabetes Care. 2003;26:917-932.
4. Anonymous. The absence of a glycemic threshold for the development of long-term complications: The perspective of the Diabetes Control and Complications Trial. Diabetes. 1996;45:1289-1298.
5. Anonymous. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes. 1995;44:968-983.
6. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837-853.
7. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352:854-865.
8. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
9. Nichols GA, Brown JB. The impact of cardiovascular disease on medical care costs in subjects with and without type 2 diabetes. Diabetes Care. 2002;25:482-486. (Pubitemid 41103340)
10. Nichols GA, Glauber HS, Brown JB. Type 2 diabetes: Incremental medical care costs during the 8 years preceding diagnosis. Diabetes Care. 2000;23:1654-1659.
11. Brown JB, Nichols GA, Glauber HS, et al. Type 2 diabetes: Incremental medical care costs during the first 8 years after diagnosis. Diabetes Care. 1999;22:1116-1124. (Pubitemid 29293965)
12. www.cdc.gov/diabetes/pubs/estimates07.htm. Accessed December 25, 2009.
13. Buchanan TA, Xiang AH, Peters RK, et al. Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women. Diabetes. 2002;51:2796-2803. (Pubitemid 34970933)
14. Torgerson JS, Hauptman J, Boldrin MN, et al. Xenical in the prevention of diabetes in obese subjects (XENDOS) study: A randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care. 2004;27:155-161. (Pubitemid 38196725)
15. Harris MI, Flegal KM, Cowie CC, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in US adults. The third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care. 1998;21:518-524.
16. Centers for Disease Control and Prevention. Prevalence of overweight and obesity among adults with diagnosed diabetes - United States, 1988- 1994, and 1999-2002. MMWR. 2004;53:1066-1068.
17. Centers for Disease Control and Prevention. Prevalence of diabetes and impaired fasting glucose in adults - United States, 1999-2000. MMWR. 2003;52:833-837.
18. Boyle JP, Honeycutt AA, Narayan KM, et al. Projection of diabetes burden through 2050: Impact of changing demography and disease prevalence in the US Diabetes Care. 2001;24:1936-1940.
19. Mainous AG III, King DE, Garr DR, et al. Race, rural residence, and control of diabetes and hypertension. Ann Fam Med. 2004;2:563-568. (Pubitemid 39643431)
20. Kirk JK, D'Agostino RB Jr, Bell RA, et al. Disparities in HbA1c levels between African-American and non-Hispanic white adults with diabetes: A meta-analysis. Diabetes Care. 2006;29:2130-2136. (Pubitemid 44871201)
21. Herman WH, Ma Y, Uwaifo G, et al. Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program Diabetes Care. 2007;30:2453-2457
22. Knowler WC, Barrett-Connor E, Fowler SE, et al. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393-403. (Pubitemid 34437694)
23. Lindstrom J, Eriksson JG, Valle TT, et al. Prevention of diabetes mellitus in subjects with impaired glucose tolerance in the Finnish diabetes prevention study: Results from a randomized clinical trial. J Am Soc Nephrol. 2003;14:S108-113.
24. Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. the Da Qing IGT and diabetes study. Diabetes Care. 1997;20:537-544.
25. From clinical trials to community: the science of translating diabetes and obesity research [conference proceedings]. www2.niddk.nih.gov/NR/rdonlyres/ 864EE73D-C876-4B30-A0EB-14E3911E2499/4589/Confpublication.pdf. Accessed March 23, 2009.
26. Diabetes Prevention Program (DPP) Research Group. The Diabetes Prevention Program (DPP): Description of lifestyle intervention. Diabetes Care. 2002;25:2165-2171.
27. Hoerger TJ, Hicks KA, Sorensen SW, et al. Cost-effectiveness of screening for pre-diabetes among overweight and obese US adults. Diabetes Care. 2007;30(11):2874-2879. (Pubitemid 350083138)
28. Herman WH, Hoerger TJ, Brandle M, et al. Diabetes Prevention Program Research Group. The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Ann Intern Med. 2005;142:323-332.
29. The DPP Research Group. Within-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes. Diabetes Care. 2003;26:2518-2523.
30. Herman WH, Brandle M, Zhang P, et al. Diabetes Prevention Program Research Group. Costs associated with the primary prevention of type 2 diabetes mellitus in the Diabetes Prevention Program. Diabetes Care. 2003;26:36-47.
31. Johnson FR, Manjunath R, Mansfield CA, et al. High-risk individuals' willingness to pay for diabetes risk-reduction programs. Diabetes Care. 2006;29:1351-1356. (Pubitemid 44125934)
32. Office of Research, Evaluation, and Planning of the National Council of the Churches ot Christ in the USA. Yearbook of American and Canadian Churches 2006. Nashville, TN: Abingdon Press; 2006.
33. Narayan KM, Gregg EW, Engelgau M, et al. Translation research for chronic disease. Diabetes Care. 2000;23:1794-1798.
34. Garfield SA, Malozowski S, Chin MH. Diabetes Mellitus Interagency Coordinating Committee (DIMCC) Translation Conference Working Group. Considerations for diabetes translational research in real-world settings. Diabetes Care. 2003;26:2670-2674.
35. Glasgow RE. Translating research to practice: Lessons learned, areas for improvement, and future directions. Diabetes Care. 2003;26:2451-2456. (Pubitemid 36993341)
36. White SL, Maloney SK. Promoting healthy diets and active lives to hard-to-reach groups: Market research study. Public Health Rep. 1990;105:224-231.
37. Underwood SM, Powell RL. Religion and spirituality: Influence on health/risk behavior and cancer screening behavior of African Americans. ABNF Journal. 2006;17(1):20-31.
38. Smith ED, Merritt SL, Patel MK. Church-based education: An outreach program for African Americans with hypertension. Ethn Health. 1997;2:243-253.
39. Castro FG, Elder J, Coe K, et al. Mobilizing churches for health promotion in Latino communities: Companeros en la salud. J Natl Cancer Inst Monogr. 1995;(18):127-135.
40. Oexmann MJ, Thomas JC, Taylor KB, et al. Short-term impact of a church-based approach to lifestyle change on cardiovascular risk in African Americans. Ethn Dis. 2000;10:17-23.
41. Wilson LC. Implementation and evaluation of church-based health fairs. J Community Health Nurs. 2000;17:39-48. (Pubitemid 30124124)
42. Campbell MK, Demark-Wahnefried W, Symons M, et al. Fruit and vegetable consumption and prevention of cancer: The Black Churches United for Better Health Project. Am J Public Health. 1999;89:1390-1396. (Pubitemid 29404564)
43. DeHaven MJ, Hunter IB, Wilder L, et al. Health programs in faith-based organizations: Are they effective? Am J Public Health. 2004;94:1030-1036.
44. Ammerman A, Corbie-Smith G, St George DM, et al. Research expectations among African American church leaders in the PRAISEI project: A randomized trial guided by community-based participatory research. Am J Public Health. 2003;93:1720-1727. (Pubitemid 38477641)
45. Corbie-Smith G, Ammerman AS, Katz ML, et al. Trust, benefit, satisfaction, and burden: A randomized controlled trial to reduce cancer risk through African-American churches. J Gen Intern Med. 2003;18:531-541. (Pubitemid 36921020)
46. Thomas SB, Quinn SC, Billingsley A, et al. The characteristics of northern Black churches with community health outreach programs. Am J Public Health. 1994;84:575-579. (Pubitemid 24140528)
47. Resnicow K, Campbell MK, Carr C, et al. Stables G. Body and soul. A dietary intervention conducted through African-American churches. Am J Prev Med. 2004;27:97-105. (Pubitemid 38942938)
48. Davis DT, Bustamante A, Brown CP, et al. The urban church and cancer control: A source of social influence in minority communities. Public Health Rep. 1994;109:500-506. (Pubitemid 24252251)
49. Oexmann MJ, Ascanio R, Egan BM. Efficacy of a church-based intervention on cardiovascular risk reduction. Ethn Dis. 2001;11:817-822.
50. Hoyo C, Reid L, Hatch J, et al. Program prioritization to control chronic diseases in African-American faith-based communities. J Natl Med Assoc. 2004;96:524-532. (Pubitemid 38437176)
51. Mann BD, Sherman L, Clayton C, et al. Screening to the converted: An educational intervention in African American churches. J Cancer Educ. 2000;15:46-50. (Pubitemid 30141635)
52. Schorling JB, Roach J, Siegel M, et al. A trial of church-based smoking cessation interventions for rural African Americans. Prev Med. 1997;26:92-101. (Pubitemid 27184630)
53. Wiist WH, Flack JM. A church-based cholesterol education program. Public Health Rep. 1990;105:381-388. (Pubitemid 20264622)
54. Yanek LR, Becker DM, Moy TF, et al. Faith based cardiovascular health promotion for African American women. Public Health Rep. 2001;116(suppl 1):68-81. (Pubitemid 32822094)
55. Levin JS. The role of the Black church in community medicine. J Natl Med Assoc. 1984;76:477-483.
56. Lasater TM, Wells BL, Carleton RA, et al. The role of churches in disease prevention research studies. Public Health Rep. 1986;101:125-131. (Pubitemid 16023367)
57. Kennedy BM, Paeratakul S, Champagne CM, et al. Lower Mississippi Delta Nutrition Intervention Research Initiative. A pilot church-based weight loss program for African-American adults using church members as health educators: A comparison of individual and group intervention. Ethn Dis. 2005;15:373-378.
58. Oexmann MJ, Thomas JC, Taylor KB, et al. Short-term impact of a church-based approach to lifestyle change on cardiovascular risk in African Americans. Ethn Dis. 2000;10(1):17-23.
59. Rolka DB, Narayan KM, Thompson TJ, et al. Performance of recommended screening tests for undiagnosed diabetes and dysglycemia. Diabetes Care. 2001;24:1899-1903. (Pubitemid 33716498)
60. American Diabetes Association. Screening for type 2 diabetes. Diabetes Care. 2000;23(suppl 1):S20-S23.
61. Dallo FJ, Weller SC. Effectiveness of diabetes mellitus screening recommendations. PNAS. 2003;100:10574-10579. (Pubitemid 37071920)